Costs and Expenses of SpringWorks Therapeutics, Inc. from 31 Dec 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
SpringWorks Therapeutics, Inc. quarterly and annual Costs and Expenses in USD history and change rate from 31 Dec 2021 to 31 Mar 2025.
  • SpringWorks Therapeutics, Inc. Costs and Expenses for the quarter ending 31 Mar 2025 was $129,623,000, a 13% increase year-over-year.
  • SpringWorks Therapeutics, Inc. annual Costs and Expenses for 2024 was $469,720,000, a 35% increase from 2023.
  • SpringWorks Therapeutics, Inc. annual Costs and Expenses for 2023 was $348,460,000, a 24% increase from 2022.
  • SpringWorks Therapeutics, Inc. annual Costs and Expenses for 2022 was $280,674,000, a 62% increase from 2021.
Source SEC data
View on sec.gov
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Change (%)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Change (%)

SpringWorks Therapeutics, Inc. Quarterly Costs and Expenses (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $129,623,000 +$14,686,000 +13% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q1 2024 $114,937,000 +$37,238,000 +48% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q1 2023 $77,699,000 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1

SpringWorks Therapeutics, Inc. Annual Costs and Expenses (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $469,720,000 +$121,260,000 +35% 01 Jan 2024 31 Dec 2024 10-K 20 Feb 2025 2024 FY
2023 $348,460,000 +$67,786,000 +24% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2025 2024 FY
2022 $280,674,000 +$107,206,000 +62% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2025 2024 FY
2021 $173,468,000 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.